2,180
Views
19
CrossRef citations to date
0
Altmetric
Breast cancer

Long-term functional and radiological pulmonary changes after radiation therapy for breast cancer

, , , &
Pages 1373-1379 | Received 03 Nov 2013, Accepted 02 Jun 2014, Published online: 18 Jul 2014

References

  • Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast- conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378: 1707–16.
  • Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087–106.
  • Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987–98.
  • Lind P. Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation. Acta Oncol 2006;45:13–5.
  • Theuws JC, Muller SH, Seppenwoolde Y, Kwa SL, Boersma LJ, Hart GA, et al. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study. J Clin Oncol 1999;17:3091–100.
  • Skoczylas JZ, Bentzen SM, Overgaard M, Overgaard J. Time course of radiological lung density changes after postmastectomy radiotherapy. Acta Oncol 2000;39:181–7.
  • Dorr W, Bertmann S, Herrmann T. Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects. Strahlenther Onkol 2005;181: 567–73.
  • Vagane R, Bruland OS, Fossa SD, Olsen DR. Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation. Acta Oncol 2008; 47:248–54.
  • Erven K, Weltens C, Nackaerts K, Fieuws S, Decramer M, Lievens Y. Changes in pulmonary function up to 10 years after locoregional breast irradiation. Int J Radiat Oncol Biol Phys 2012;82:701–7.
  • Jaen J, Vazquez G, Alonso E, De Las Penas MD, Diaz L, De Las Heras M, et al. Long-term changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study with 7-year follow-up. Int J Radiat Oncol Biol Phys 2012;84:e565–70.
  • Lind PA, Bylund H, Wennberg B, Svensson C, Svane G. Abnormalities on chest radiographs following radiation therapy for breast cancer. Eur Radiol 2000;10:484–9.
  • Lind PA, Wennberg B, Gagliardi G, Fornander T. Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat 2001;68: 199–210.
  • Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, et al. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer 2002;94:2821–9.
  • Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001;93:1806–11.
  • Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996;88:918–22.
  • Bjermer L, Franzen L, Littbrand B, Nilsson K, Angstrom T, Henriksson R. Effects of smoking and irradiated volume on inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. Cancer Res 1990;50:2027–30.
  • Arriagada R, de Guevara JC, Mouriesse H, Hanzen C, Couanet D, Ruffie P, et al. Limited small cell lung cancer treated by combined radiotherapy and chemotherapy: Evaluation of a grading system of lung fibrosis. Radiother Oncol 1989;14:1–8.
  • Lind PA, Svane G, Gagliardi G, Svensson C. Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999;43: 489–96.
  • Lind PA, Rosfors S, Wennberg B, Glas U, Bevegard S, Fornander T. Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother Oncol 1998;49:245–54.
  • Bergh J, Wiklund T, Erikstein B, Lidbrink E, Lindman H, Malmstrom P, et al. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: A randomised trial. Scandinavian Breast Group 9401 study. Lancet 2000;356:1384–91.
  • Lehne G, Lote K. Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review. Acta Oncol 1990;29:113–24.
  • McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31:1187–203.
  • Kahan Z, Csenki M, Varga Z, Szil E, Cserhati A, Balogh A, et al. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007;68:673–81.
  • Jaen J, Vazquez G, Alonso E, Leon A, Guerrero R, Almansa JF. Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study. Int J Radiat Oncol Biol Phys 2006;65:1381–8.
  • Franzen L, Bjermer L, Henriksson R, Littbrand B, Nilsson K. Does smoking protect against radiation-induced pneumonitis? Int J Radiat Biol 1989;56:721–4.
  • Blom Goldman U, Wennberg B, Svane G, Bylund H, Lind P. Reduction of radiation pneumonitis by V20- constraints in breast cancer. Radiat Oncol 2010;5:99.
  • Blom Goldman U, Anderson M, Wennberg B, Lind P. Radiation pneumonitis and pulmonary function with lung dose-volume constraints in breast cancer irradiation. J Radiother Practice 2014;13:211–7.
  • Blom-Goldman U, Svane G, Wennberg B, Lideståhl A, Lind PARM. Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer. Acta Oncol 2007;46:187–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.